More Related Content
Similar to CVS Pathology 5 Thromboembolism 2019, sufia husain
CVS Pathology 5 Thromboembolism 2019, sufia husain
- 1. Sufia Husain Associate Professor PathologyDepartment College of Medicine KSU, Riyadh February 2019 Reference: Robbins & Cotran Pathology and Rubin’s Pathology Thromboembolism
- 2. Understand thebasic pathology of thrombogenesis and the risk factors for development of deep vein thrombosis. Know the types of embolus than can occur and the pathology of pulmonary embolism. Key principles to be discussed: Pathological aspects of thrombogenesis: vessel wall abnormality, vascular stasis or turbulent flow and increased blood coagulability. Causes of thrombus and embolism formation. Predisposing factors for deep vein thrombosis. Pathology of pulmonary thrombo-embolism. Brief description of other forms of emboli like: fat embolism, air embolism, atherosclerotic plaque embolism, amniotic fluid embolism, nitrogen embolism and infective endocarditis. Objectives: At the end of this lecture, the student should:
- 3. Understand the basicpathology of thrombogenesis. Pathological aspects of thrombogenesis: vessel wall abnormality, vascular stasis or turbulent flow and increased blood coagulability. Predisposing risk factors for development of deep vein thrombosis. Pathology of pulmonary thrombo-embolism. Embolism. Know the types of embolus than can occur and the pathology of pulmonary embolism. Brief description of other forms of emboli like: fat embolism, air embolism, atherosclerotic plaque embolism, amniotic fluid embolism. Lecture outline
- 4. Thrombosis It isa process by which a thrombus is formed. It represents hemostasis in the intact vascular system. A thrombus is a solid mass (blood clot) made up of blood constituents which develops in artery or vein. It is intravascular coagulation of blood and it often causes significant interruption to blood flow. research.vet.upenn.edu600 × 323Search by image (aortic thrombus) www.veinatlanta.com Vein Atlanta, Louis Prevosti, MD
- 5.
- 6. Three primary influencescalled as Virchow triad predispose to thrombus formation: (1) endothelial injury (2) stasis or turbulence of blood flow (3) blood hypercoagulability It results from interaction of platelets, damaged endothelial cells and the coagulation cascade. All 3 are component of the hemostatic process. Pathogenesis
- 7. Components of thehemostatic process 1. Endothelial cells are resistant to the thrombogenic influence of platelets and coagulation proteins. Intact endothelial cells are thromboresistant. 2. Platelets maintain the integrity of the vascular endothelium and participate in endothelial repair. They form platelet plugs and promote the coagulation cascade. 3. Coagulation Cascade is a major contributor to thrombosis. It is a series of enzymatic conversions, that end in the formation of thrombin. Thrombin then converts the soluble plasma protein fibrinogen into the insoluble protein fibrin. And fibrin is a constituent of the thrombus.
- 8. Fibrinolysis (thrombus dissolution) Activationof the clotting cascade induces coagulation. It also triggers the fibrinolytic cascade that limits the size of the final clot. It runs concurrently with thrombogenesis. Fibrinolytic cascade helps dissolve the thrombus and therefore restores blood flow in vessels occluded by the thrombus. In the fibrinolytic cascade the inactive proenzyme plasminogen is converted to active plasmin. Plasmin then splits the fibrin in the thrombus. The thrombus is dissolved by plasmin.
- 9. Figure 4-13 Virchowtriad in thrombosis. Endothelial integrity is the single most important factor. Note that injury to endothelial cells can affect local blood flow and/or coagulability; abnormal blood flow (stasis or turbulence) can, in turn, cause endothelial injury. The elements of the triad may act independently or may combine to cause thrombus formation. Downloaded from: Robbins & Cotran Pathologic Basis of Disease (on 1 April 2005 07:37 PM) © 2005 Elsevier
- 10. The endotheliumis a single cell thick lining of endothelial cells and it is the inner lining of the entire cardiovascular system (arteries, veins and capillaries) and the lymphatic system. It is in direct contact with the blood/lymph and the cells circulating in it. Endothelial structural and functional integrity is fundamental to the maintenance of vessel wall homeostasis and normal circulatory function. ENDOTHELIAL CELLS www.udel.edu
- 11. The following conditions leadto chronic subtle endothelial dysfunction/injury: Hypertension Scarred valves Bacterial endotoxins Radiation Hypercholesterolemia Cigarette smoking Endothelial Injury is a major cause of thrombosis in the heart or arteries Endothelial injury leads to: Exposure of subendothelial ECM i.e the basement membrane Adhesion of platelets Release of tissue factor and ultimately thrombosis NOTE: Endothelial injury can contribute to thrombosis in several clinical settings e.g: Endocardial injury due to myocardial infarction Ulcerated plaques in atherosclerotic arteries Traumatic or inflammatory vascular injury 1) Endothelial Injury
- 12. Abnormal blood flow:disruption of laminar blood flow can bring platelets into contact with the endothelium and promote endothelial cell activation 1.Stasis plays a major role in the development of venous thrombi 2.Turbulence contributes to arterial and cardiac thrombosis by causing endothelial injury or dysfunction NOTE: Abnormal blood flow contributes to thrombosis in several clinical settings: Ulcerated atherosclerotic plaques Abnormal aortic and arterial dilations Acute myocardial infarction Mitral valve stenosis Hyperviscosity syndromes Sickle cell anemia 2) Abnormal Blood Flow
- 13. Definition: Any changeof the coagulation pathways that predisposes to thrombosis Hypercoagulability can be divided into: Primary (inherited) hypercoagulable states Secondary (acquired) hypercoagulable states 3) Hypercoagulability
- 14. Hypercoagulable states canbe 1. Primary/Genetic (e.g. mutation in factor V gene or prothrombin gene, anti-thrombin III deficiency, protein C or S deficiencies, or fibrinolysis defects. 2. Secondary/acquired states: they can be high risk or low risk a) High risk for thrombosis Prolonged bed rest or immobilization Myocardial infarction, Atrial fibrillation Tissue damage (surgery, fracture, burns) Cancer Prosthetic cardiac valves Disseminated intravascular coagulation Heparin-induced thrombocytopenia Antiphospholipid antibody syndrome (lupus anticoagulant syndrome) b) Lower risk for thrombosis Cardiomyopathy, Nephrotic syndrome, Hyperestrogenic states (pregnancy), Oral contraceptive use, Sickle cell anemia, Smoking. Hypercoaguable States
- 15. Can beanti-thrombotic (hemorrhagic), leading to pathologic bleeding states such as hemophilia, Christmas disease and von Willebrand disease. Can also be prothrombotic, leading to hypercoagulability with pathologic thrombosis e.g. hereditary thrombophilia and antiphospholipid antibody syndrome. Thrombotic disorders
- 16. Pro-thrombotic conditions Hereditary Thrombophilia Isa prothrombotic familial syndrome. Characterized by recurrent venous thrombosis and thromboembolism Can be caused by deficiency of antithrombotic proteins e,g. antithrombin3, protein C, and protein S. Factor V Leiden thrombophiliais a genetically inherited prothrombotic disorder of blood. Factor V Leiden is a mutated form of human factor V that causes an increase in blood clotting (hypercoagulability). Antiphospholipid antibody syndrome Is a prothrombotic hypercoagulable autoimmune multisystem disorder caused by the presence of antiphospholipid antibodies. Is characterized by recurrent thrombosis and embolism and fetal loss in pregnancy. Patients have prolonged partial thromboplastin time (PTT). It is sometimes associated Systemic Lupus Erythematosus and so this antibody is also known as lupus anticoagulant.
- 17. Is bothprothrombotic and antithrombotic disorder characterized by widespread thrombosis and hemorrhage resulting from the consumption of platelets and coagulation factors. Disseminated intravascular coagulation
- 18. Morphology of thrombus •Thrombi may develop anywhere in the cardiovascular system, the cardiac chambers, valve cusps, arteries, veins, or capillaries. They vary in size and shape, depending on the site of origin. • Arterial or cardiac thrombi usually begin at a site of endothelial injury (e.g., atherosclerotic plaque) or turbulence (vessel bifurcation). Venous thrombi characteristically occur in sites of stasis. • Arterial thrombi grow in a retrograde direction from the point of attachment (i.e. toward the heart). Venous thrombi extend in the direction of blood flow (i.e. toward the heart). • The propagating tail of either thrombi may not be well attached (particularly in veins) is prone to fragmentation, creating an embolus
- 19. Morphology of thrombus(cont.) A thrombus is made up of fibrin, platelets and red blood cell and few inflammatory cells. Mural thrombus webpathology.com www.sciencephoto.com When arterial thrombi arise in heart chambers or in the aortic lumen they are termed mural thrombi. Abnormal myocardial contraction or endomyocardial injury promotes cardiac mural thrombi.
- 20. Lines of Zahn Thrombiformed in the heart or aorta may have apparent laminations, called lines of Zahn seen grossly (and microscopically). Lines of Zahn are produced by alternating pale layers of platelets admixed with some fibrin and darker layers containing more red cells.
- 21. Clinical effects ofthrombosis: Clinical effects depend on the site of thrombosis. Thrombi are significant because: They cause obstruction of arteries and veins They are potential sources of emboli Venous thrombi have capacity to embolize to the lungs and can cause death. Arterial thrombi can cause vascular obstruction at critical sites and cause serious consequence e.g. ischemia and necrosis.
- 22. are usuallyocclusive most common sites in descending order, are coronary, cerebral, and femoral arteries. It is usually superimposed on an atherosclerotic plaque and are firmly adherent to the injured arterial wall. Arterial thrombi are gray-white and friable. Arterial thrombi symptomat.de400 × 267Search by image Arteriosklerose mit verstopfter Arterie und einem Blutgerinnsel (Thrombus).
- 23. Also calledphlebothrombosis, is almost invariably occlusive the thrombus often takes the shape of the vein. Because these thrombi form in a relatively static environment, they contain more enmeshed erythrocytes and are therefore known as red, or stasis thrombi. Phlebothrombosis most commonly affects the veins of the lower extremities (90% of cases). www.uaz.edu.mx600 × 395Search by image Femoral vein, recent thrombus Venous thrombosis ak47boyz90.wordpress.com
- 24. Sterile vegetations: •Nonbacterial thrombotic endocarditis(marantic): is noninfected vegetations on valves in patients with hypercoagulable states subtle endothelial abnormalities and some patients with malignancy and other debilitating diseases. •Patients with systemic lupus erythematosus can have noninfective, verrucous (Libman-Sacks) endocarditis. Infective vegetations: •Infective endocarditis: bacterial or fungal blood-borne infections may result in the development of large thrombotic masses on heart valves. Thrombi on Heart Valves Thrombi on Heart Valves are called as vegetations. They can be infective or sterile.
- 25.
- 26. Deep vein thrombosis& Thrombophlebitis Venous thrombosis often arises in the deep veins of the legs and then it is called deep vein thrombosis (DVT). They occur with stasis or in hypercoagulable states. Often associated with inflammation and then it is termed thrombophlebitis DVT may embolize to the lungs giving rise to pulmonary embolism with resultant pulmonary infarct. • Common in deep the larger leg veins— at or above the knee (e.g., popliteal, femoral, and iliac veins) • DVTs are asymptomatic in approximately 50% of affected individuals.
- 27. Deep vein thrombosis embolize travels to right side of heart to lungs pulmonary embolism with resultant pulmonary infarct. www.steadyhealth.com
- 28. Deep vein thrombosis Commonpredisposing factors for DVT (same as factors predisposing to hypercoagulable state): 1. Bed rest and immobilization 2. Congestive heart failure (a cause of impaired venous return) 3. Trauma, surgery, and burns 4. Pregnancy: the potential for amniotic fluid infusion into the circulation at the time of delivery can cause thrombogenesis late pregnancy and the postpartum period are also associated with systemic hypercoagulability 1. Tumors 2. Advanced age
- 29. Postmortem clots At autopsy,postmortem clots may be confused for venous thrombi. Postmortem clots Red thrombi • Are gelatinous. • Are firmer. • They have a dark red dependent portion where red cells have settled by gravity and a top layer of yellow fat supernatant resembling melted and clotted chicken fat. • On cut section reveal vague strands of pale gray fibrin. • They are not attached to the underlying wall. • Almost always have a point of attachment.
- 30. Fate of Thrombus Resolution Propagation Embolism Organizationand recanalization Organization and incorporation into the wall.
- 31. Downloaded from: Robbins& Cotran Pathologic Basis of Disease (on 1 April 2005 08:23 PM) © 2005 Elsevier Fate of thrombus
- 32.
- 33. • An embolus(pleural emboli)is a detached intravascular solid, liquid, or gaseous mass that is carried by the blood to a site distant from its point of origin. • Majority of the emboli represent some part of a dislodged thrombus, hence the commonly used term thromboembolism. • The emboli ultimately lodged in vessels too small to permit further passage, resulting in partial or complete vascular occlusion leading to ischemic necrosis of distal tissue, (infarction). Depending on the site of origin, emboli may lodge in the pulmonary or systemic circulations. EMBOLISM www.steadyhealth.com
- 34. Pulmonary thromboembolism Systemic thromboembolism Fat embolism Air embolism Amniotic fluid embolism Types of embolism
- 35. • Embolus getlodged in the pulmonary vasculature. • Depending on size of embolus, it may occlude main pulmonary artery, or impact across the bifurcation (saddle embolus), or pass out into the smaller, branching arterioles of the pulmonary circulation. • Rarely, embolus may pass through an interatrial or interventricular defect to gain access to the systemic circulation (paradoxical embolism). • Most pulmonary emboli (60-80%) are clinically silent because they are small. Sudden death, right heart failure (cor pulmonale) occurs when more than 60% of the pulmonary circulation is obstructed by emboli. • Embolic obstruction may result in infarction. PULMONARY THROMBOEMBOLISM R L
- 37. refers to embolitraveling within the arterial circulation. Most (80%) arise from intracardiac mural thrombi. The major sites for arteriolar embolization are the lower extremities (75%) and the brain (10%). The consequences of systemic emboli depend on the extent of collateral vascular supply in the affected tissue, the tissue's vulnerability to ischemia, and the caliber of the vessel occluded; in general, arterial emboli cause infarction of tissues supplied by the artery SYSTEMIC THROMBOEMBOLISM
- 38. • Microscopic fatglobules may be found in the circulation after fractures of long bones (which have fatty marrow) or, rarely, in soft tissue trauma and burns. • Fat is released by marrow or adipose tissue injury and enters the circulation through rupture of the blood vessels and act as an embolus. • Less than 10% of patients with fat embolism have any clinical findings. • Fat embolism syndrome is characterized by pulmonary insufficiency, neurologic symptoms, anemia, and thrombocytopenia. FAT EMBOLISM
- 39. Gas bubbleswithin the circulation can obstruct vascular flow (and cause distal ischemic injury) acting as thrombotic masses. Bubbles may coalesce to form frothy masses sufficiently large to occlude major vessels. Air may enter the circulation during obstetric procedures or as a consequence of chest wall injury. An excess of 100 cc is required to have a clinical effect. AIR EMBOLISM
- 40. • Occurs whenindividuals are exposed to sudden changes in atmospheric pressure. • Scuba and deep sea divers, underwater construction workers, and individuals in unpressurized aircraft in rapid ascent are all at risk. • When air is breathed at high pressure (e.g. during a deep sea dive), increased amounts of gas (particularly nitrogen) become dissolved in the blood and tissues. If the diver then ascends (depressurizes) too rapidly, the nitrogen expands in the tissues and bubbles out of solution in the blood to form gas emboli. • ‘Bends’ i.e. joint/muscle pain and ‘chokes’ i.e. respiratory distress. • Treatment: placing the individuals in a compression chamber where the barometric pressure may be raised, thus forcing the gas bubbles back into solution followed by subsequent slow decompression. • A more chronic form of decompression sickness is called caisson disease in which, persistence of gas emboli in the skeletal system leads to multiple foci of ischemic necrosis; the more common sites are the heads of the femurs, tibia, and humeri. Air embolism: decompression sickness
- 41. AMNIOTIC FLUID EMBOLISM •A grave and uncommon complication of labor and the immediate postpartum period, caused by infusion of amniotic fluid or fetal tissue into the maternal circulation via a tear in the placental membranes or rupture of uterine veins. • Characterized by sudden severe dyspnea, cyanosis, and hypotensive shock, followed by seizures and coma. • If the patient survives the initial crisis, pulmonary edema develops, along with disseminated intravascular coagulation, owing to release of thrombogenic substances from amniotic. • Microscopy: presence in the pulmonary microcirculation of squamous cells shed from fetal skin, fetal hair, fetal fat etc. Marked pulmonary edema and diffuse alveolar damage are also present. Systemic fibrin thrombi indicative of DIC can also be seen.